ArticlePDF Available

Abstract

La diabetes, debido a sus complicaciones, es una de las enfermedades que más problemas plantean en la salud pública actual mundial. En este trabajo se parte de una población de diabéticos con y sin complicaciones y se asocia un problema de control optimal no lineal que describe la dinámica de la población. Para este modelo se prueba la existencia del estado de equilibrio y que es un punto de ensilladura. Además se obtuvo que no existen ciclos límite, lo que es un resultado importante, dado el problema que se describe. Se presentan ejemplos para los cuales el estado de equilibrio que se caracteriza no es necesariamente admisible.
REVISTA DE MATEMÁTICA: TEORÍA Y APLICACIONES 2018 25(2) : 239–259
CIMPA UCR IS SN : 1409-2433 (PRINT), 2215-3373 (ONLINE)
DOI:https://doi.org/10.15517/rmta.v25i2.33692
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL
CONTROL PROBLEM OF A POPULATION
OF DIABETICS
INEXISTENCIA DE CICLO LÍMITE EN UN
PROBLEMA DE CONTROL ÓPTIMO DE
UNA POBLACIÓN CON DIABETES
SÉVERINE BERNARDTÉNISSIA CÉSAR
SILVÈRE P. NUIROALAIN PTRUS§
Received: 21/Jun/2017; Revised: 7/May/2018;
Accepted: 16/May/2018
Laboratoire de Mathématiques Informatique et Applications, Université des Antilles, Guade-
loupe, France. E-Mail: severine.bernard@univ-antilles.fr
Misma dirección que/Same address as: S. Bernard. E-Mail: tenissia.cesar@univ-antilles.fr
Misma dirección que/Same address as: S. Bernard. E-Mail: paul.nuiro@univ-antilles.fr
§Misma dirección que/Same address as: S. Bernard. E-Mail: alain.pietrus@univ-antilles.fr
239
240 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
Abstract
This paper deals with one of the most important public health problem
in the whole world that is diabetes, and more precisely its complications.
From a model examining the complications or not of a population of dia-
betics, we associate a nonlinear optimal control problem. Considering the
previous, we prove that the equilibrium state exists and is a saddle point.
Moreover, we claim the unexistence of limit cycle in such a population,
which is an interesting result concerning this world evil. Then we give
some examples for which we characterize the equilibrium state which is
not necessarily admissible.
Keywords: two-dimensional optimal control model; limit cycle; equilibrium
state; Hopf bifurcation theorem.
Resumen
La diabetes, debido a sus complicaciones, es una de las enfermedades
que más problemas plantean en la salud pública actual mundial. En este
trabajo se parte de una población de diabéticos con y sin complicaciones y
se asocia un problema de control óptimo no lineal que describe la dinámica
de la población. Para este modelo se prueba la existencia del estado de
equilibrio y que es un punto de ensilladura. Además se obtuvo que no
existen ciclos límite, lo que es un resultado importante, dado el problema
que se describe. Se presentan ejemplos para los cuales el estado de equi-
librio que se caracteriza no es necesariamente admisible.
Palabras clave: modelo de control optimal bi-dimensional; ciclo límite; estado
de equilibrio; teorema de bifurcación de Hopf.
Mathematics Subject Classification: 49J15, 34H05, 34H20, 90C46, 34C05.
1 Introduction
Diabetes is a chronic disease caused by a combination of hereditary and acquired
bad factors, like family antecedents, overweight, unhealthy diet, physical inac-
tivity. It occurs when the pancreas is not able to product insulin or when the
body can not use effectively the insulin it makes. Consequently, the glucose
from the diet stays in the blood instead of being transferred into the cells in or-
der to produce energy. But a constant high glucose level in the blood causes a
lot of damage to various organs and tissues, like kidney failure, blindness and
eyes problems, heart attack, lower limb amputation and many other ones. The
treatment is based on medication, healthy diet and physical exercises. Accord-
ing to the International Diabetes Federation, approximately 425 million adults
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 241
were living with diabetes in the whole world in 2017, which caused 4million
deaths and 727 bilion USD in health expenditure. Moreover, 352 million people
were at risk of developing diabetes. In particular, it concerned more than 3.5
million of persons in France in 2016 and more than 9percent of the population
of the archipelago of Guadeloupe, from the website of the French Federation of
Diabetics. Its progression is stagerring in developed countries and even more in
developing ones. Due to the mortality rate and the health expenditure caused by
this evil, it is important to understand the triggering factors of the disease and its
evolution.
There are in the literature many mathematical studies focused on this topic
and everything related to it [1, 2, 3, 4, 5, 6, 9, 11, 12]. The different existing
mathematical models are based on ordinary differential equations [4, 11, 12],
partial differential equations [11], delay differential equations [10, 11, 13, 14]
and stochastic differential equations [11]. An overview of some mathematical
models and software tools for the glucose-insulin regulatory system and diabetes
has been done in [11]. In the last decades, some models focused on the intra-
venous glucose tolerance test, which consists to observe how a body reacts after
the injection of a large amount of glucose [13], whereas other ones focused on
the subcutaneous injection of insulin (see [17] and [9] for an overview). Another
approach was to analyse the evolution of diabetes to the stage of complications
[4] and an interesting one was given in [5] where the authors attempt to model
mathematically the diabetes progression.
The blood glucose issue has also been seen as a control problem. In [6], J. R.
Faria showed, by using the Hopf bifurcation theorem adapted to optimal control
problem, that there is a cyclical behavior between the weight and the consump-
tion of a diabetic created by the medical treatment. In [3], the authors consid-
ered an optimal control problem for the evolution of numbers of pre-diabetics
and diabetics with and without complications and showed that the population of
diabetics with complications decreases when an optimal control is applied. In
[2], S. Bernard and A. Piétrus considered a new model of regulation adapted to
the one introduced in [12] and studied it in the framework of ordinary differen-
tial equations and optimal control theory. By controlling the external glucose
food intake, they proved that the plasma glycemia level can be minimized. In
our previous work [1], we considered a population of diabetics, divided into two
subcategories, one of diabetics with complications and another one of diabet-
ics without complications as in [4]. From the model examining the complica-
tions of individuals diagnosed with diabetes, we associated a nonlinear optimal
control problem, for which we proved that there is no cyclical behavior be-
tween the number of diabetics with complications, the one of diabetics without
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
242 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
complications and the rate at which complications are healed. Moreover, as we
considered a nonlinear optimal control problem with a scalar control and two
states for which necessary conditions of an optimal control are well known, we
could characterize the equilibrium point by using an adaptation of the Hopf bi-
furcation theorem to optimal control models as it has been done in [7, 18, 19, 20].
This work can be seen as a generalization of the previous one [1]. Indeed,
we prove the existence of an optimal control and an equilibrium state whatever
the controlled parameter and for any concave performance index, whereas in
[1], it has been done in a particular case. Moreover, we are still able to claim
that there is no limit cycle between the number of diabetics with complications
and the one of diabetics without complications and that the equilibrium state is
always a saddle point, which is an encouraging result since it reflects the unex-
istence of a back and forth between these two subcategories of diabetics, when
the probability of developing complications or their cure rate are controlled.
Consequently, Section 2 is devoted to the study of the two dimensional non-
linear optimal control problem, that is we show the existence of an optimal con-
trol and characterize it via the Pontryagin’s maximum principle. In Section 3,
the stability analysis leads us to prove that the equilibrium state always exists
and is a saddle point. In Section 4, by studying some suitable examples, we
characterize the equilibrium state and see that it is not always admissible. We
finish by some concluding remarks and perspectives.
2 Optimal control problems in a population of diabetics
We begin with the mathematical model of [4] in which we choose to put all the
parameters depending on the time
D(t) = I(λ(t) + µ(t))D(t) + γ(t)C(t),
C(t) = λ(t)D(t)(γ(t) + µ(t) + ν(t) + δ(t))C(t),(1)
where:
tis the time,
D(.)the number of diabetics without complications,
C(.)the number of diabetics with complications,
Ithe incidence of diabetes,
λ(.)the probability of developing a complication,
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 243
µ(.)the natural mortality rate,
γ(.)the rate at which complications are healed,
ν(.)the rate at which patients with complications become severely dis-
abled,
δ(.)the mortality rate due to complications.
Sometimes, we will omit the tin order to relieve the writing. According
to [4], this model has been constructed by considering a population in which I
cases are diagnosed with diabetes on a time interval. During this period of time,
the number of diabetics without complications decreases in order to naturally
death with rate µor develop complications with rate λ, and also increases with
the amount of diabetics with healed complications, with rate γ. In the same
period of time, the number of diabetics with complications decreases with this
last amount, the natural death, the mortality due to complications with rate δand
severely disabled patients with rate νand increases by the coming of diabetics
developing complications. The only one thing we add in this model is the fact
that all the rates depend on the time, which seems more realistic.
Theoretically, any parameter of the model, that is λ(.),µ(.),γ(.),ν(.)or
δ(.), can be chosen as control, but in practice, this is not possible since we can
not control the natural mortality rate for example. In this state of minds, we can
control the probability of developing complications by informing the diabetic
patients on a necessary good lifestyle with physical activity and healthy diet.
We can also control the rate at which complications are healed or the rate at
which patients with complications become severely disabled, with an increase
of health expenditure. Consequently, in the following, ucan be chosen as λ(.),
γ(.)or ν(.). The following result is a classical one and is just cited in order to
well pose the optimal control problem.
Theorem 1 For all fixed control u, there exists one and only one maximal solu-
tion [0, tm(u)], Du(.), Cu(.)of the Cauchy problem (1) with the initial condi-
tions Du(0) = D0IR+,Cu(0) = C0IR+and tm(u)IR+∪ {+∞}.
Remark 1 The values of Dand Cwill depend on the specific choice of the
control u. We underline this dependence by using Duand Cu, instead of Dand
Crespectively.
For a fixed discount rate r > 0, our aim is to maximize the objective function
+
0
exp(rt)Fu(t), D(t), C (t)dt,
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
244 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
where F(u, D, C )is a concave performance index. In practice, our aim would
be to minimize the complications in a population of diabetics. Consequently, F
can be a concave function, increasing with respect to u=γand/or Dand/or
decreasing with respect to u=λ,u=νand/or C. From these choices, we have
this second classical result.
Theorem 2 Let (D0, C0)be in IR2
+such that there is a control u(.)satisfying (1)
with the initial conditions D(0) = D0and C(0) = C0. There exists an optimal
control ¯udefined on [0,+[such that the associated trajectory (D¯u(.), C¯u(.))
satisfies (1), the initial conditions and which maximizes
+
0
exp(rt)Fu(t), D(t), C (t)dt.
In order to characterize this optimal control, we apply as usual the
Pontryagin’s maximum principle. We refer the reader to [15] and [8, 16, 18]
for more details and different applications of the optimal control theory.
Theorem 3 With previous assumptions, there exists an application
P(.) = (PD(.), PC(.)) : [0,+[IR2absolutely continuous called adjoint
vector, such that, for almost all t0,
P
D(t) = (r+λ(t) + µ(t))PD(t)λ(t)PC(t)
∂F
∂D (u(t), D(t), C(t)),
P
C(t) = (r+γ(t) + µ(t) + ν(t) + δ(t))PC(t)γ(t)PD(t)
∂F
∂C (u(t), D(t), C(t)),
with the limiting transversality conditions:
lim
t+exp(rt)PD(t)D(t) = 0,
lim
t+exp(rt)PC(t)C(t) = 0.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 245
And the optimal control ¯u, whose existence has been proved in previous theorem,
satisfies the following maximization’s condition:
Hu, D, C, PD, PC) = max
vL(IR+)H(v, D, C, PD, PC),
where His the associated Hamiltonian defined from the state equations and the
concave performance index F(u, D, C)as
H(u, D, C, PD, PC) = F(u, D, C) + PD[I(λ+µ)D+γC]
+PC[λD (γ+µ+ν+δ)C].
3 Stability analysis
This section is devoted to the existence proof of the equilibrium state and its
classification. In our previous work [1], we fixed a control, a cost function and
characterized the associated equilibrium state to see under which conditions it is
admissible. In the present one, we prove that the equilibrium state exists what-
ever the control and the objective function.
Theorem 4 Whatever the control uand whatever the concave performance in-
dex Fchosen as previously specified, there is an equilibrium state for the system
D(t) = I(λ(t) + µ(t))D(t) + γ(t)C(t),
C(t) = λ(t)D(t)(γ(t) + µ(t) + ν(t) + δ(t))C(t),
P
D(t) = (r+λ(t) + µ(t))PD(t)λ(t)PC(t)
∂F
∂D (u(t), D(t), C(t)),
P
C(t) = (r+γ(t) + µ(t) + ν(t) + δ(t))PC(t)γ(t)PD(t)
∂F
∂C (u(t), D(t), C(t)).
Proof. The equilibrium state (D, C, P
D, P
C), if it exists, is solution of the
following system
I(λ(t) + µ(t))D(t) + γ(t)C(t) = 0,
λ(t)D(t)(γ(t) + µ(t) + ν(t) + δ(t))C(t) = 0,
(r+λ(t) + µ(t))PD(t)λ(t)PC(t)
∂F
∂D (u(t), D(t), C(t))= 0,
(r+γ(t) + µ(t) + ν(t) + δ(t))PC(t)γ(t)PD(t)
∂F
∂C (u(t), D(t), C(t))= 0.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
246 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
In order to have existence of an equilibrium state, we evaluate the determi-
nant of this last system which is on the form
S=
(λ+µ)γ0 0
λ(γ+µ+ν+δ) 0 0
. . r +λ+µλ
. . γ r +γ+µ+ν+δ
.
An easy computation gives
S= [λ(µ+ν+δ) + µ(γ+µ+ν+δ)]
·[(r+µ)(r+γ+µ+ν+δ) + λ(r+µ+ν+δ)] ,
which implies that S0and Sis clearly equal to zero if and only if all the
parameters of the model are equals to zero, since Sis a sum of non negative
terms. Consequently, Sis strictly non negative, which implies the existence of
an equilibrium state.
In order to characterize this equilibrium state, we have to choose the control
and the objective function. We will see in the following section some examples
for which we characterize it and note that it is not necessarily admissible.
Theorem 5 There is no limit cycle between the number of diabetics with compli-
cations, the one of diabetics without complications and the controlled parameter
chosen as previously specified.
Proof. The steps leading to this result are similar to the ones of [1]. Let us define
the Jacobian by
J=
∂D/∂D ∂D/∂C ∂D/∂PD∂D/∂PC
∂C /∂D ∂C/∂C ∂C/∂PDC/∂PC
∂P
D/∂D ∂P
D/∂C ∂ P
D/∂PD∂ P
D/∂PC
∂P
C/∂D ∂ P
C/∂C ∂P
C/∂PD∂ P
C/∂PC
,
and a term Kby
K=
∂D/∂D ∂D/∂PD
∂P
D/∂D ∂P
D/∂PD
+
∂C /∂C ∂C/∂PC
∂P
C/∂C ∂ P
C/∂PC
+2
∂D/∂C ∂D/∂PC
∂P
D/∂C ∂ P
D/∂PC
.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 247
In order to study the existence of a limit cycle, it is necessary to know the
sign of the determinant of the Jacobian Jand of the term Kcalculated at the
equilibrium point. For our problem, we have
J=
(λ+µ)γ0 0
λ(γ+µ+ν+δ) 0 0
2F
∂D22F
∂C D r+λ+µλ
2F
∂D∂C 2F
∂C 2γ r +γ+µ+ν+δ
,
and
K=
(λ+µ) 0
2F
∂D2r+λ+µ
+
(γ+µ+ν+δ) 0
2F
∂C 2r+γ+µ+ν+δ
+2
γ0
2F
∂C D
λ
.
Even if the matrix Jand the term Kare more general than the ones of our
previous study [1], we obtain exactly the same results for det Jand K, that is
det J= [λ(µ+ν+δ) + µ(γ+µ+ν+δ)]
·[(r+µ)(r+γ+µ+ν+δ) + λ(r+µ+ν+δ)] ,
and
K=(λ+µ)(r+λ+µ)
(γ+µ+ν+δ)(r+γ+µ+ν+δ)2γλ.
It is clear that det J0and K0, which leads to the result.
Theorem 6 The equilibrium state defined previously is a saddle point.
Proof. In order to classify the equilibrium state, we have to know the sign of
Q= det(J)1
2K2. Since det(J)and Kare exactly the same than those of [1],
we used a similar method.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
248 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
4 Characterization of the equilibrium state in
particular cases
In this section, we are going to characterize the equilibrium state, whose ex-
istence has been proved in the previous one, for different concave performance
index. We will see that it is not always easy to characterize it and even if we can,
it is not necessarily admissible taking into account the specificities of our prob-
lem. In the following, we consider the rate at which complications are healed as
control, that is u=γand for a fixed discount rate r > 0, the cost function we
want to maximize is
+
0
exp(rt)Fu(t), D(t), C (t)dt,
where F(u, D, C )is the concave performance index that we will fix at each case.
In the first example, we choose the control u=γand the performance
index F(u, D, C) = ln u. In this case, our goal is to control the rate at which
complications are healed while maximizing it.
Proposition 1 If the control u=γand the performance index
F(u, D, C ) = ln uthen the associated equilibrium state is not admissible.
Proof. According to Section 2, we have the existence of the optimal control lead-
ing to maximize the rate at which complications are cured. In order to character-
ize it, we use the Pontryagin’s maximum principle which gives the existence of
an adjoint vector P(.)=(PD(.), PC(.)) : [0,+[R2absolutely continuous
such that, for almost all t>0,
P
D(t) = (r+λ(t) + µ(t))PD(t)λ(t)PC(t),
P
C(t) = γ(t)PD(t)+(r+γ(t) + µ(t) + ν(t) + δ(t))PC(t),
with the associated Hamiltonian
H(γ, D, C, PD, PC) = ln γ+PD[I(λ+µ)D+γC] + PC[λD (γ+µ+ν+δ)C],
and the previously cited limiting transversality conditions. Consequently, the
optimal control is
¯γ=1
(PCPD)C.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 249
Now, we try to characterize the associated equilibrium state of the system
D(t) = I(λ(t) + µ(t))D(t) + γ(t)C(t),
C(t) = λ(t)D(t)(γ(t) + µ(t) + ν(t) + δ(t))C(t),
P
D(t) = (r+λ(t) + µ(t))PD(t)λ(t)PC(t),
P
C(t) = γ(t)PD(t)+(r+γ(t) + µ(t) + ν(t) + δ(t))PC(t),
by solving
I(λ+µ)D+ ¯γC = 0,
λD γ+µ+ν+δ)C= 0,
(r+λ+µ)PDλPC= 0,
¯γPD+ (r+ ¯γ+µ+ν+δ)PC= 0.
By replacing ¯γby 1
(PCPD)C, we have
I(λ+µ)D+1
PCPD
= 0,
λD (µ+ν+δ)C1
PCPD
= 0,
(r+λ+µ)PDλPC= 0,
(r+µ+ν+δ)PC+1
C= 0.
The use of the first, fourth and second equations gives successively
D=I(PCPD)+1
(λ+µ)(PCPD),
C=1
(r+µ+ν+δ)PC
,
and λI
λ+µ+µ+ν+δ
(r+µ+ν+δ)PC
µ
(λ+µ)(PCPD)= 0.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
250 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
Moreover, with the third equation, we obtain
PD=λ
r+λ+µPCso PCPD=r+µ
r+λ+µPC.
Consequently,
D=I
λ+µ+(r+λ+µ)
(r+µ)(λ+µ)PC
,
and λI
λ+µ+µ+ν+δ
(r+µ+ν+δ)PC
µ(r+λ+µ)
(r+µ)(λ+µ)PC
= 0,
so
PC=r[µ(r+µ)λ(ν+δ)]
λI(r+µ)(r+µ+ν+δ).
Thus, the equilibrium state is
D=I
λ+µ+λI(r+λ+µ)(r+µ+ν+δ)
r(λ+µ)[µ(r+µ)λ(ν+δ)],
C=λI(r+µ)
r[µ(r+µ)λ(ν+δ)],
P
D=r[µ(r+µ)λ(ν+δ)]
I(r+µ)(r+λ+µ)(r+µ+ν+δ),
P
C=r[µ(r+µ)λ(ν+δ)]
λI(r+µ)(r+µ+ν+δ).
Note that, if the term µ(r+µ)λ(ν+δ)is equal to zero then PC=PD= 0
which is impossible since (PD, PC)has to be non trivial. It follows that
γ=(r+λ+µ)(r+µ+ν+δ)
r+µ.
However, this equilibrium state is not admissible because γis a rate so has
to be non negative.
In the second example, we choose the control u=γand the performance
index F(u, D, C) = ln u+aln C, with a > 0. In this case, our goal is to
control the rate at which complications are healed while maximizing the number
of diabetics with cured complications.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 251
Proposition 2 If the control u=γand the performance index
F(u, D, C ) = ln u+aln C, with a > 0, then the associated equilibrium state
is admissible if and only if a > 1.
Proof. According to Section 2, we have the existence of the optimal control lead-
ing to maximize the number of diabetics with cured complications. In order to
characterize it, we use the Pontryagin’s maximum principle which gives the ex-
istence of an adjoint vector P(.) = (PD(.), PC(.)) : [0,+[R2absolutely
continuous such that, for almost all t>0,
P
D(t) = (r+λ(t) + µ(t))PD(t)λ(t)PC(t),
P
C(t) = γ(t)PD(t) + (r+γ(t) + µ(t) + ν(t) + δ(t))PC(t)a
C(t),
with the associated Hamiltonian
H(γ, D, C, PD, PC) = ln γ+aln C+PD[I(λ+µ)D+γC ]
+PC[λD (γ+µ+ν+δ)C],
and the previously cited limiting transversality conditions. Consequently, the
optimal control is
¯γ=1
(PCPD)C.
We characterize the associated equilibrium state by solving
I(λ+µ)D+1
PCPD
= 0,
λD (µ+ν+δ)C1
PCPD
= 0,
(r+λ+µ)PDλPC= 0,
(r+µ+ν+δ)PC+1a
C= 0.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
252 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
Similar computations give the following equilibrium state:
D=I
λ+µ[1 + λ(r+λ+µ)(r+µ+ν+δ)
(µ+ν+δ)(a1)(r+µ)(λ+µ) + µ(r+λ+µ)(r+µ+ν+δ)],
C=λI(a1)(r+µ)
(µ+ν+δ)(a1)(r+µ)(λ+µ) + µ(r+λ+µ)(r+µ+ν+δ),
P
D=(µ+ν+δ)(a1)(r+µ)(λ+µ) + µ(r+λ+µ)(r+µ+ν+δ)
I(r+µ)(r+µ+ν+δ)(r+λ+µ),
P
C=(µ+ν+δ)(a1)(r+µ)(λ+µ) + µ(r+λ+µ)(r+µ+ν+δ)
λI(r+µ)(r+µ+ν+δ).
It follows that
γ=(r+λ+µ)(r+µ+ν+δ)
(r+µ)(a1) ,
and this equilibrium state is admissible if and only if a > 1.
In the last example, we choose the control u=γand the performance index
F(u, D, C ) = αln u+aln C+K(D), with a, α > 0and Kan increasing
concave function of D. In this case, our goal is to control the rate at which
complications are healed while maximizing the number of diabetics with cured
complications and the number of diabetics without complications.
Proposition 3 Let us set σ=µ+ν+δand assume that the control u=γand
the performance index F(u, D, C) = αln u+aln C+K(D), with a, α > 0
and Kan increasing concave function of D. If µ= 0 and
if K(D) = Dthen, the associated equilibrium state is admissible if and
only if α < a σ1Iand r > σI
σ(aα)I,
or if K(D) = ln Dand a > λ
σthen, there is αsatisfying
0< α<min a, λ
2σ+λ,
and r>0such that the associated equilibrium state is admissible.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 253
Proof. As previously, we have the existence of the optimal control leading to
maximize the number of diabetics with cured complications and the number of
diabetic without complications. In order to characterize it, we use the
Pontryagin’s maximum principle which gives the existence of an adjoint vec-
tor P(.)=(PD(.), PC(.)) : [0,+[R2absolutely continuous such that, for
almost all t>0,
P
D(t) = (r+λ(t) + µ(t))PD(t)λ(t)PC(t)K(D(t)),
P
C(t) = (r+γ(t) + µ(t) + ν(t) + δ(t))PC(t)γ(t)PD(t)a
C(t),
with the associated Hamiltonian
H(γ, D, C, PD, PC) = αln γ+aln C+K(D) + PD[I(λ+µ)D+γC]
+PC[λD (γ+µ+ν+δ)C],
and the previously cited limiting transversality conditions. Consequently, the
optimal control is
¯γ=α
(PCPD)C.
We characterize the equilibrium state by solving
I(λ+µ)D+α
PCPD= 0,
λD (µ+ν+δ)Cα
PCPD= 0,
(r+λ+µ)PDλPCK(D)=0,
(r+µ+ν+δ)PC+αa
C= 0.
In order to simplify the writing, let us set ρ=λ+µand T=PCPD. The
use of the first and second equations gives
D=IT +α
ρT and C=λ
σDα
σT .
Consequently,
C=λ(α+I T )αρ
σρT .
Moreover, by using the fourth equation, we obtain
PC=aα
(r+σ)Cso PC=(aα)σρT
(r+σ)[λIT +α(λρ)].
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
254 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
Let us note that the quantity λIT +α(λρ)is equal to zero if and only if
C= 0 which has no sense in this situation. Moreover, the third equation implies
that
PD=λT σρ(aα)+(r+σ)[λI T +α(λρ)]K(D)
(r+σ)(r+ρ)[λIT +α(λρ)] .
Thus
T=(r+ρ)(aα)σρT λT σ ρ(aα)(r+σ)[λIT +α(λρ)]K(D)
(r+σ)(r+ρ)[λIT +α(λρ)] ,
which is equivalent to
λI(r+ρ)(r+σ)T2
+α(λρ)(r+ρ)(r+σ)(r+ρλ)(aα)σρ +λIK(D)(r+σ)T
+α(r+σ)(λρ)K(D) = 0.
At this stage, it is not easy to characterize Texplicitly. We use the fact that
µ= 0 that is λ=ρso
T=σ(aα)rI(r+σ)K(D)
I(r+λ)(r+σ),
since Tis different from zero. Consequently, Tdepends on the derivative of
the function K. In order to finish the characterization, we consider two different
cases.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 255
The first one is K(D) = Dfor which we obtain
T=σ(aα)rI(r+σ)
I(r+λ)(r+σ).
Consequently
D=I
λ+αI(r+λ)(r+σ)
λ[σ(aα)rI(r+σ)],
C=I
σ,
P
D=λ(aα)σ+ (r+σ)I
(r+σ)(r+λ)I,
P
C=(aα)σ
(r+σ)I.
It follows that
γ=ασ(r+λ)(r+σ)
σ(aα)rI(r+σ).
This equilibrium state is admissible if and only if σ(aα)rI(r+σ)>0. As
saying in [1], it occurs if and only if α < a σ1Iand r > σI
σ(aα)I.
The second case we consider is K(D) = ln Dfor which we obtain
T=σ(aα)rD I(r+σ)
I(r+λ)(r+σ)D.
Replacing Dby IT +α
ρT , we get
(r+λ)(r+σ)I2T2+[(r+σ)ρ+α(r+λ)(r+σ)(aα)]I T (aα)αrσ = 0.
This is a polynomial equation on the form pT 2+qT +l= 0 with
p= (r+λ)(r+σ)I2,
q= [(r+σ)ρ+α(r+λ)(r+σ)(aα)]I ,
l=rασ(αa).
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
256 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
If a>αthen the associated discriminant ∆ = q24lp is strictly non
negative and consequently, there are two solutions
T=1
2pq±q24lp.
If q < 0then there is one non negative solution T, which ensures the existence
of an admisible equilibrium state. But qis negative if and only if
αr2+ [λ+α(σ+λ) + σ(αa)]r+σλ(1 + α)<0,(2)
wich occurs only when
λ+α(σ+λ) + σ(αa)<0,
and for this, we need that > λ and 0< α < λ
2σ+λ. Moreover, we remark
that the discriminant of (2):
β(α) = [λ(1 + α)]24ασ2(aα),
is such that
lim
α0+β(α) = [λ]2>0.
So, there is α>0such that α<min a, λ
2σ+λand β(α)>0,since
βis a continuous function on ]0, a[. Therefore, it exists r>0solution of (2).
Finally, the equilibrium state is
D=1
λI+2
q+q24lp ,
C=I
σ,
P
D=λ(aα)σ
I(r+σ)(r+λ)+
λq+q24lp
(r+λ)I(q+q24lp)+2,
P
C=(aα)σ
I(r+σ),
and it follows that
γ=α
TC=2pασ
I(q+q24lp),
which is admissible.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 257
5 Concluding remarks
This work is clearly a generalization of our previous one [1]. Considering a pop-
ulation of diabetics, we proved that there is no cyclical behavior between the
number of diabetics with complications and the one of those without complica-
tions, when an optimal control is applied; that the equilibrium state always exists
but is not always admissible and fortunately is always a saddle point. This result
is an interesting one and reassures us since it reflects the fact that if we control
the rate at which complications are healed, or the rate at which patients with
complications become severely disabled or the probability of developing com-
plications, by more health expenditure or a good lifestyle respectively, then there
is no back and forth between the group of diabetics with complications and the
one of diabetics without complications. In the following, it will be interesting
to see how external actions like medication, food consumption or physical ex-
ercises can impact on the development of complications for diabetics. The first
challenge would be to see how to include these parameters in the model and the
second one to measure their impact on the disease and its evolution.
Acknowledgments
We would like to thank the anonymous referees for their valuable suggestions
and remarks that enabled us to improve the presentation of this manuscript.
References
[1] Bernard, S.; Nuiro, S.P.; Piétrus, A. (2015) “Diabetes, complications and
limit cycles”, Applied Mathematics E-Notes 15: 197–206.
[2] Bernard, S.; Piétrus, A. (2015) “Optimal glucose modelling for diabetes”,
e-Journal of the Caribbean Academy of Sciences 8(1): 1–8.
[3] Boutayeb, A.; Boutayeb, W.; Lamlili, M. (2014) “Optimal control ap-
proach to the dynamics of population of diabetics”, Applied Mathematical
Sciences 8(56): 2773–2782.
[4] Boutayeb, A.; Chetouani, A.; Achouyab, A.; Twizell, E.H. (2006) “A non-
linear population model of diabetes mellitus”, Journal of Applied Mathe-
matics and Computing 21(1-2): 127–139.
[5] De Gaetano, A.; Hardy, T.; Beck, B.; Abu-Raddad, E.; Palumbo,
P.; Bue-Valleskey, J.; Porksen, N. (2008) “Mathematical models of
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
258 S.BERNARD T.SAR S.P.NUIRO -A.PIÉT RUS
diabetes progression”, American Journal of Physiology, Endocrinology
and Metabolism 295(6) : E1462–E1479.
[6] Faria, J.R. (2003) “Limit cycles in an optimal control problem of diabetes”,
Applied Mathematics Letters 16(1): 127–130.
[7] Feichtinger, G.; Novak, A.; Wirl, F. (1994) “Limit cycles in intertemporal
adjustment models: theory and applications”, Journal of Economic Dy-
namics and Control 18(2) : 353–380.
[8] Grass, D.; Caulkins, J.P.; Feichtinger, G.; Tragler, G.; Behrens, D.A. (2008)
Optimal Control of Nonlinear Processes, With Applications in Drugs, Cor-
ruption, and Terror. Springer-Verlag Berlin Heidelberg, Germany.
[9] Li, J.; Johnson, J. D. (2009) “Mathematical models of subcutaneous injec-
tion of insulin analogues: a mini-review”, Discrete and Continuous Dy-
namical Systems-Series B 12(2): 401–414.
[10] Li, J.; Kuang, Y. (2007) “Analysis of a model of the glucose-insulin reg-
ulatory system with two delays”, SIAM Journal on Applied Mathematics
67(3): 757–776.
[11] Makroglou, A.; Li, J.; Kuang, Y. (2006) “Mathematical models and soft-
ware tools for the glucose-insulin regulatory system and diabetes: an
overview”, Applied Numerical Mathematics 56(3-4): 559–573.
[12] Meilûnas, M. (1998) “On the blood glucose dynamics modelling”, Mathe-
matical Modelling and Analysis 3(1): 136–139.
[13] Mukhopadhyay, A.; De Gaetano, A.; Arino, O. (2004) “Modelling the
intra-venous glucose tolerance test: a global study for a single-distributed-
delay model”, Discrete and Continuous Dynamical Systems. Series B 4(2):
407–417.
[14] Palumbo, P.; Pepe, P.; Panunzi, S.; De Gaetano, A. (2009) “Robust closed-
loop control of plasma glycemia: A discrete-delay model approach”, Dis-
crete and Continuous Dynamical Systems. Series B 12(2): 455–468.
[15] Pontryagin, L.; Boltyanski, V.; Gamkrelidze, R.; Michtchenko, E. (1974)
Théorie mathématique des processus optimaux. Éditions Mir, Moscou.
[16] Trélat, E. (2008) Contrôle optimal: Théorie et applications. Vuibert, Paris,
France.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
UNEXISTENCE OF LIMIT CYCLE IN AN OPTIMAL CONTROL . . . 259
[17] Wang, H.; Li, J.; Kuang, Y. (2007) “Mathematical modelling and qual-
itative analysis of insuline therapies”, Mathematical Biosciences 210(1):
17–33.
[18] Wirl, F. (1992) “Cyclical strategies in two-dimensional optimal control
models: necessary conditions and existence”, Annals of Operations Re-
search 37(1): 345–356.
[19] Wirl, F. (1996) “Pathways to Hopf bifurcations in dynamic continuous-time
optimization problems”, Journal of Optimization Theory and Applications
91(2) : 299–320.
[20] Wirl, F.; Feichtinger, G. (2010) “Modelling social dynamics (of obesity)
and thresholds”, Games 1(4): 395–414.
Rev.Mate.Teor.Aplic. (ISSN print: 1409-2433; online: 2215-3373) Vol. 25(2): 239–259, Jul–Dec 2018
Book
This book brings together two important discussions in public health in developing countries: an understanding of the burden of disease, health equity and social determinants of health; and biomathematical models, epidemiological studies and estimation of the direct and indirect cost of disease. The empirical chapters in the first part discuss aspects of disease prevention and health promotion in developing countries, with a particular focus on countries that are part of the World Health Organization’s Eastern Mediterranean Region and the African Region. World. Health equity and social determinants of health constitute a cornerstone of this book, with the widespread recognition that addressing the social determinants of health is crucial not only for improving general health but importantly for reducing unfair and remediable health inequalities. Using mathematical models, epidemiological studies and statistical estimation of costs, the second part of this book shows the opportunities that exist for developing countries to prevent disease and promote health by adopting cost-effective strategies and cost–benefit analyses.
Chapter
A nonlinear discrete mathematical model is presented for the interactions between tumor cells and oncolytic virotherapy. Positive equilibrium points of the system are investigated and their stability analysis is examined. Moreover, the numerical simulation of the proposed model is also performed by using numerical method which preserves the theoretical properties. The uninfected tumor cells can be eliminated with time, and complete recovery is possible because of virus therapy, if suitable conditions are satisfied. The system appears to exhibit periodic cycles and chaotic behavior for some values of the system parameters.
Chapter
This chapter is devoted to a review of compartmental mathematical models used for diabetes. Usually, compartmental models are used for communicable diseases for which dynamics is governed by the evolution of the disease based on the number of susceptible people that may become infected after a contact with infectious people. However, disease transmission is not a mandatory condition for the evolution from one compartment to another. In the case of diabetes, the main problem is not with diabetes but rather with complications of diabetes. Consequently, it is interesting to consider the evolution of diabetic people from the stage of diabetes without complication (compartment D) to the stage of diabetes with complications (compartment C) in order to see how to avoid or at least to delay as far as possible occurrence of complications. Stressing that dynamic should not be regarded in the usual way of transmitted diseases but rather as a probabilistic evolution from one stage to another, many authors have considered the evolution from pre-diabetes or diabetes without complications to diabetes with complications. Different mathematical tools were and are used, including discrete mathematics, ordinary differential equations, partial differential equations, optimal control, numerical approximations and stochastic approaches.
Thesis
Full-text available
Thesis for the Diploma of Habilitation to Lead Research, defended on 12 December 2018 at the University of the French West Indies (Guadeloupe)+
Article
Full-text available
Diabetes is a chronic disease with a huge and growing socio-economic burden affecting individuals, families and the whole society. In this paper, we propose an optimal control approach modeling the evolution from pre-diabetes to diabetes with and without complications. We show the existence of an optimal control and then use a numerical implicit finite-difference method to monitor the size of population in each compartment. Our model shows that, using optimal control, the number of diabetics with and without complications can be significantly reduced in a period of 10 years.
Article
Full-text available
A mathematical study of the size of a population ofdiabetes mellitus patients is carried out in this paper. The study also monitors the number of patients with complications. By appropriate definition of a parameter, the mathematical model may be classified as linear or non-linear. The non-linear case is discussed and the critical values of the population are analysed for stability. Numerical methods are developed for solving the model equations and the results of numerical simulations are reported.
Article
Full-text available
The Intra Venous Glucose Tolerance Test (IVGTT) is a simple and established experimental procedure in which a challenge bolus of glucose is administered intra-venously and plasma glucose and insulin concentrations are then frequently sampled. The modeling of the measured concentrations has the goal of providing information on the state of the subject's glucose/insulin control system: an open problem is to construct a model representing simulta-neously the entire control system with a physiologically believable qualitative behavior. A previously published single-distributed-delay differential model was shown to have desirable properties (positivity, boundedness, global stabil-ity of solutions) under the hypothesis of a specific, square-wave delay integral kernel. The present work extends the previous results to a family of mod-els incorporating a generic non-negative, square integrable normalized kernel. Every model in this family describes the rate of glucose concentration variation as due to both insulin-dependent and insulin-independent net glucose tissue uptake, as well as to constant liver glucose production. The rate of variation of plasma insulin concentration depends on insulin catabolism and on pancreatic insulin secretion. Pancreatic insulin secretion at time t is assumed to depend on the earlier effects of glucose concentrations, up to time t (distributed delay). We consider a non-negative, square integrable normalized weight function ω on R + = [0, ∞) as the fraction of maximal pancreatic insulin secretion at a given glucose concentration. No change in local asymptotic stability is intro-duced by the time delay. Considering an appropriate Lyapunov functional, it is found that the system is globally asymptotically stable if the average time delay has a parameter-dependent upper bound. An example of good model fit to experimental data is shown using a specific delay kernel.
Article
Full-text available
An overview of some of the mathematical models appearing in the literature for use in the glucose-insulin regulatory system in relation to diabetes is given, enhanced with a survey on available software. The models are in the form of ordinary differential, partial differential, delay differential and integro-differential equations. Some computational results are also presented.
Article
In this paper, we consider a population of diabetics and divide it into two subcategories, one of diabetics with complications and another one of diabetics without complications. From a model examining the complications of individu- als diagnosed with diabetes, we associate a nonlinear optimal control problem. Considering this last one, we prove that there is no cyclical behavior between dia- betics with complications, diabetics without complications and the rate at which complications are cured. Moreover we characterize the state equilibrium via Hopf bifurcation theorem adapted to optimal control problem.
Article
A mathematical model of glucose regulation is proposed and discussed. It is based only on the data, which are available in outpatient clinics. This model enables to predict the state of the patients’ health and to identificate important parameters of patients’ organisms, which are urgent in diabetology.
Article
This paper starts from well-behaved (i.e., concave) one-state-variable optimal control models. The crucial feature is that indigenous growth is present. The replacement of the control by an adjustment process and presumably penalizing these adjustments may convert stable (and only stable) fixed point equilibria into limit cycles. Indeed, given positive growth and proper externalities (such that discounting exceeds growth), one can generate stable limit cycles with ease, e.g., for a separable framework. Examples from such diverse fields as renewable resources, optimal saving and public choice highlight the economic applicability.
Article
This paper derives necessary conditions such that cyclical policies may be optimal in concave, two state variable (economic) control problems. These conditions identify four different routes. One major implication is that two of these four conditions may be met by separable models. This possibility has been overlooked so far. Therefore, even separable and structurally very simple models may be characterized by optimal cyclical policies. Indeed, it will be shown that stable limit cycles exist for concave and separable control problems.
Article
The purpose of this paper is to characterize pathways to Hopf bifurcation in continuous time, concave, two-dimensional optimal control models. It is shown that essentially two pathways exist: control-state interaction and growth. The knowledge of such pathways provides a criterion at the stage of modelling on the potential complexity of optimal trajectories.
Article
This article examines the behaviour of an individual diagnosed with diabetes. It is shown that the medical treatment of the disease creates incentives that make a diabetic's consumption, weight, and labour supply display cyclical patterns. The existence of a limit cycle is proved using an adaptation of the Hopf bifurcation theorem for optimal control problems.